SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-06-002125
Filing Date
2006-09-11
Accepted
2006-09-11 06:59:55
Documents
4
Period of Report
2006-07-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT pphm_10q-073106.htm 10-Q 780466
2 CERTIFICATION OF CEO pphm_10qex31-1.htm EX-31.1 12217
3 CERTIFICATION OF CFO pphm_10qex31-2.htm EX-31.2 12481
4 CERTIFICATION pphm_10ex-32.htm EX-32 13381
  Complete submission text file 0001019687-06-002125.txt   820145
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 061083003
SIC: 2835 In Vitro & In Vivo Diagnostic Substances